Cullen Frost Bankers Inc. decreased its position in shares of Humana Inc. (NYSE:HUM) by 8.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,113 shares of the insurance provider’s stock after selling 105 shares during the period. Cullen Frost Bankers Inc.’s holdings in Humana were worth $268,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Independent Portfolio Consultants Inc. increased its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Guardian Life Insurance Co. of America boosted its position in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares in the last quarter. Point72 Asia Hong Kong Ltd acquired a new position in Humana during the first quarter worth approximately $128,000. Westbourne Investment Advisors Inc. acquired a new position in Humana during the second quarter worth approximately $205,000. Finally, Hengehold Capital Management LLC acquired a new position in Humana during the second quarter worth approximately $209,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Shares of Humana Inc. (NYSE HUM) opened at 254.96 on Thursday. The firm’s 50-day moving average price is $238.81 and its 200-day moving average price is $222.35. The stock has a market cap of $36.85 billion, a price-to-earnings ratio of 20.97 and a beta of 0.91. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $255.10.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter in the previous year, the firm posted $2.30 earnings per share. On average, analysts forecast that Humana Inc. will post $11.45 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/cullen-frost-bankers-inc-sells-105-shares-of-humana-inc-hum/1468576.html.

A number of research analysts have recently commented on HUM shares. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $237.00 target price on the stock in a research note on Tuesday, April 18th. Jefferies Group LLC cut Humana from a “buy” rating to a “hold” rating and cut their target price for the company from $237.00 to $221.00 in a research note on Friday, April 21st. Cowen and Company reaffirmed an “outperform” rating and set a $230.00 target price on shares of Humana in a research note on Tuesday, April 25th. Evercore ISI reaffirmed an “outperform” rating and set a $240.00 target price on shares of Humana in a research note on Tuesday, April 25th. Finally, Cantor Fitzgerald upped their target price on Humana from $190.00 to $200.00 and gave the company a “neutral” rating in a research note on Wednesday, April 26th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $243.65.

In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the transaction, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the completion of the transaction, the vice president now owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The disclosure for this sale can be found here. Insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.